Cargando…

Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer

Ovarian cancer is the most lethal gynecologic malignancy, characterized by late diagnosis, frequent relapse, and easy development of chemoresistance. Recent studies suggest that lncRNAs are involved in ovarian cancer onset and progression, as well as the resistance in paclitaxel-containing chemother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Luqing, Hu, Yanjun, Xiang, Xiaohong, Qu, Kai, Teng, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609994/ https://www.ncbi.nlm.nih.gov/pubmed/28969062 http://dx.doi.org/10.18632/oncotarget.19828

Ejemplares similares

Autophagy-related long non-coding RNA signature for ovarian cancer
por: Meng, Chan, et al.
Publicado: (2020)

Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis
por: Hu, Yanjun, et al.
Publicado: (2017)

Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer
por: Wu, Qianxue, et al.
Publicado: (2021)

Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma
por: Hao, Fengjie, et al.
Publicado: (2021)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
por: Gu, Jing-Xian, et al.
Publicado: (2019)

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2023)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas
por: Tian, Suyan, et al.
Publicado: (2020)

A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer
por: Pan, Xue, et al.
Publicado: (2021)

Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
por: Sun, Xiaoyu, et al.
Publicado: (2021)

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties
por: HAN, XIAOFENG, et al.
Publicado: (2013)

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties
por: Han, Xiaofeng, et al.
Publicado: (2022)

A long non-coding RNA signature for predicting survival in patients with colorectal cancer
por: Wang, Yi-Lin, et al.
Publicado: (2017)

Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
por: Wang, Jiao, et al.
Publicado: (2023)

Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma
por: Yu, Xiaolin, et al.
Publicado: (2020)

Identification of a four-long non-coding RNA signature in predicting breast cancer survival
por: Zhu, Mingjie, et al.
Publicado: (2020)

miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations
por: Teng, Yue, et al.
Publicado: (2016)

Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma
por: Shang, Chao, et al.
Publicado: (2019)

Identification of a dinucleotide signature that discriminates coding from non-coding long RNAs
por: Ulveling, Damien, et al.
Publicado: (2014)

Long non-coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma
por: Tian, Xin, et al.
Publicado: (2019)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer
por: Hou, Jian, et al.
Publicado: (2022)

Comprehensive analysis of candidate signatures of long non-coding RNA LINC01116 and related protein-coding genes in patients with hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2023)

Expression signatures of long non-coding RNA and mRNA in human traumatic brain injury
por: Yang, Li-Xiang, et al.
Publicado: (2019)

Coronary Artery Thrombosis Associated With Paclitaxel in Advanced Ovarian Cancer
por: Park, Sang-Ho, et al.
Publicado: (2009)

An autophagy‐related long non‐coding RNA signature for glioma
por: Luan, Fangkun, et al.
Publicado: (2019)

Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies
por: Baghdadi, Hamed, et al.
Publicado: (2023)

Identification of monotonically expressed long non-coding RNA signatures for breast cancer using variational autoencoders
por: Wang, Dongjiao, et al.
Publicado: (2023)

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
por: Tan, Xiangbin, et al.
Publicado: (2023)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer
por: Fan, Qiaowei, et al.
Publicado: (2016)

Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer
por: Zhong, Wenwen, et al.
Publicado: (2022)

Identification and function of long non-coding RNA
por: Ernst, Carl, et al.
Publicado: (2013)

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
por: Zhao, Qiu-Jie, et al.
Publicado: (2018)

Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma
por: Zheng, Zhiyuan, et al.
Publicado: (2021)

Identification of potential prognostic long non-coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma
por: Wang, Xiaojuan, et al.
Publicado: (2018)

Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2022)

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
por: Sandercock, J, et al.
Publicado: (2002)

First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.
por: Sandercock, J., et al.
Publicado: (1998)

Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p7pm5nir4l9ud7ojb3uampsndv